+43.1%
GSK vs VT
+57.0%
-14.0%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | VT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.4% | -0.3% | -0.1% | -0.3% |
| 7D | +0.2% | +2.4% | -2.1% | -0.7% |
| 30D | +5.4% | -1.5% | +6.9% | +5.9% |
| 3M | +0.9% | -4.1% | +5.0% | +2.5% |
| 6M | +0.7% | +0.6% | +0.2% | +0.2% |
| YTD | +5.6% | +11.0% | -5.4% | +0.6% |
| 1Y | +8.5% | +13.3% | -4.8% | +2.5% |
| 3Y | +63.8% | +73.4% | -9.6% | +28.7% |
| All | +43.1% | +57.0% | -14.0% | +13.2% |
Cumulative growth
Daily Returns
Daily percentage return beside VT.
Daily Out/Under-Performance
Portfolio return minus VT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded VT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling